These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34097168)

  • 1. Orexin A Suppresses the Expression of Exosomal PD-L1 in Colon Cancer and Promotes T Cell Activity by Inhibiting JAK2/STAT3 Signaling Pathway.
    Wen J; Chang X; Bai B; Gao Q; Zhao Y
    Dig Dis Sci; 2022 Jun; 67(6):2173-2181. PubMed ID: 34097168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis.
    Pradhan R; Paul S; Acharya SS; Sinha S; Dash SR; Kundu CN
    J Nutr Biochem; 2024 Mar; 125():109568. PubMed ID: 38185347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides.
    Altves S; Guclu E; Yetisgin E; Bilecen K; Vural H
    World J Microbiol Biotechnol; 2024 May; 40(7):204. PubMed ID: 38755413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
    Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
    Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer.
    Yan XL; Luo QY; Zhou SN; Pan WT; Zhang L; Yang DJ; Qiu MZ
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101574. PubMed ID: 33272890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5.
    Guru SA; Sumi MP; Mir R; Waza AA; Bhat MA; Zuberi M; Lali P; Saxena A
    Hum Cell; 2020 Oct; 33(4):1099-1111. PubMed ID: 32430672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer.
    Li H; Chen X; Zheng S; Han B; Zhang X; Zheng X; Lu Y; Sun Q; Hu X; Wu J
    J Transl Med; 2024 Sep; 22(1):821. PubMed ID: 39227816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
    Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
    Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
    Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
    J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 inhibition reduced PD-L1 expression and enhanced antitumor immune responses.
    Jahangiri A; Dadmanesh M; Ghorban K
    J Cell Physiol; 2020 Dec; 235(12):9457-9463. PubMed ID: 32401358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer cells synergistically defend against CD8
    Li D; Zhou X; Xu W; Chen Y; Mu C; Zhao X; Yang T; Wang G; Wei L; Ma B
    Cancer Med; 2023 Aug; 12(15):16405-16415. PubMed ID: 37501397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
    Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
    Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway.
    Wen Z; Sun H; Zhang Z; Zheng Y; Zheng S; Bin J; Liao Y; Shi M; Zhou R; Liao W
    Cancer Commun (Lond); 2023 May; 43(5):562-581. PubMed ID: 37031362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21.
    Wang H; Qi Y; Lan Z; Liu Q; Xu J; Zhu M; Yang T; Shi R; Gao S; Liang G
    Gene Ther; 2023 Feb; 30(1-2):88-100. PubMed ID: 35440807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway.
    Chen Y; Li F; Li D; Liu W; Zhang L
    Clin Immunol; 2021 Jun; 227():108728. PubMed ID: 33878452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin inhibits colon cancer malignant progression and promotes T cell killing by regulating miR-206 expression.
    Tong Q; Wu Z
    Clin Anat; 2024 Jan; 37(1):2-11. PubMed ID: 37191314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer cells promote CD169
    Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
    Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway.
    Li X; Wang S; Mu W; Barry J; Han A; Carpenter RL; Jiang BH; Peiper SC; Mahoney MG; Aplin AE; Ren H; He J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):41. PubMed ID: 35086548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of low-dose radiation-induced upregulation of immune checkpoint molecule expression in lung cancer cells.
    Wan X; Fang M; Chen T; Wang H; Zhou Q; Wei Y; Zheng L; Zhou Y; Chen K
    Biochem Biophys Res Commun; 2022 Jun; 608():102-107. PubMed ID: 35397421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.